| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/15/2003 | US6593512 Transgenic mouse expressing human tau gene |
| 07/15/2003 | US6593463 Malarial merozite surface protein (MSP); modified nucleic acid sequence; AT content has been reduced by replacing codons with mammary gland preferred codons; useful in development of a vaccine against malaria |
| 07/15/2003 | US6593461 Isolated DNA of given nucleotide sequence which encodes an amino acid sequence; hybridization; use in diagnosing, preventing and treating gastrointestinal disorders |
| 07/15/2003 | US6593459 Compound for use in the treatment of cancer |
| 07/15/2003 | US6593456 Polypeptide for use in the treatment rheumatoid arthritis |
| 07/15/2003 | US6593305 Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase |
| 07/15/2003 | US6593304 Recombinant dna comprising dna coding for myosin heavy chain sm1 iso-form protein inserted into vector dna microorganism carrying the recombinant dna, and an agent for treatment of arteriosclerosis comprising the recombinant dna |
| 07/15/2003 | US6593297 Compounds and methods for inhibiting cancer metastasis |
| 07/15/2003 | US6593293 Bacillus thuringiensis strains comprising novel crystal proteins which exhibit insecticidal activity against lepidopteran insects |
| 07/15/2003 | US6593273 Method for reducing pest damage to corn by treating transgenic corn seeds with pesticide |
| 07/15/2003 | US6593141 Scorpion toxins |
| 07/15/2003 | US6593137 Antibodies specific for fullerenes |
| 07/15/2003 | US6593135 Quantitative analysis |
| 07/15/2003 | US6593134 Propagation of chicken infectious anemia virus; prepare nutrient broth, inoculate with cells infected with marek's disease, propagate, recover infected cells |
| 07/15/2003 | US6593133 Neurotrophic factors |
| 07/15/2003 | US6593132 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 07/15/2003 | US6593129 Apparatus for use in the injection of material into amphibian oocytes |
| 07/15/2003 | US6593126 Human kinase and polynucleotides encoding the same |
| 07/15/2003 | US6593124 Hybrid genes for expression of stimulatory factors in activated T cells |
| 07/15/2003 | US6593122 Nucleotide sequences coding enzymatic polypeptide for use as tools in genetic engineering |
| 07/15/2003 | US6593121 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of nervous system disorders |
| 07/15/2003 | US6593120 Nucleic acid which encodes a single-chain polypeptide having polymerase and RNase activity; DNA sequence encoding contiguous histidine residues; fragment comprising promoter sequence, ribosome binding site and origin of replication |
| 07/15/2003 | US6593119 Core 2 β-1,6-N-acetylglycosaminyltransferase gene |
| 07/15/2003 | US6593117 Protein for use in food processing |
| 07/15/2003 | US6593116 Transgenic microbial polyhydroxyalkanoate producers |
| 07/15/2003 | US6593114 Staphylococcus aureus polynucleotides and sequences |
| 07/15/2003 | US6593113 In vitro method for providing templates for DNA sequencing |
| 07/15/2003 | US6593112 Polynucleotides encoding fibroblast growth factor 15 |
| 07/15/2003 | US6593111 Generating genetically engineered viral genome; obtain clones, incubate with restriction enzymes, recover nucleotide sequence, ligate and generate viral genome |
| 07/15/2003 | US6593109 Culturing cells containing DNA sequences under the control of a regulatory sequence capable of directing expression; useful in treating bone defects, healing bone injury and wounds |
| 07/15/2003 | US6593108 Nucleic acid molecule encoding a melanin-concentrating hormone receptor 2 polypeptide |
| 07/15/2003 | US6593107 Methods of refolding proteins |
| 07/15/2003 | US6593106 Methods of refolding proteins |
| 07/15/2003 | US6593105 Vector comprising a nucleic acid insert; alteration of amino acids within the helix-1 region; inability to convert to a disease-associated form; use in prophylaxis/gene therapy for neurodegenerative diseases |
| 07/15/2003 | US6593099 Nucleotide sequences coding enzymatic polypeptide for use in the treatment and prevention cardiovascular disease, hyperlipidemia, dietetics and diabetes |
| 07/15/2003 | US6593092 Amplification; detection |
| 07/15/2003 | US6593090 Providing a device for detecting presence of target nucleic acid molecule; contacting probes with sample which may have target nucleic acid molecule under selective hybridization conditions, determining if electrical current can be carried |
| 07/15/2003 | US6593089 Polymeric substrate, mask layer having projected surface area and topographical surface area that is greater than the projected surface area, linking agents on mask layer |
| 07/15/2003 | US6593087 Nucleic acid from a nematode or an arthropod pest, encoding a P-glycoprotein homolog which regulates resistance to a macrocyclic lactone |
| 07/15/2003 | US6593086 Nucleic acid amplification methods |
| 07/15/2003 | US6593082 DNA oligonucleotide comprising the viral polymerase promoter; amplification; transcribing and translating the products in eukaryotic cell-free lysates in presence of a radio-labelled agent; measuring the priming activity |
| 07/15/2003 | US6593081 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 07/15/2003 | US6593079 Method for simultaneous detection of HIV antigens and HIV antibodies |
| 07/15/2003 | US6592877 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 07/15/2003 | US6592876 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| 07/15/2003 | US6592874 Togavirus capsid particle that does not contain genomic or RNA vector replicon nucleic acids |
| 07/15/2003 | US6592873 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids |
| 07/15/2003 | US6592870 Method and kit using recombinant proteins in fusion of porcine reproductive and respiratory syndrome virus and for diagnosis |
| 07/15/2003 | US6592868 Produced by hybridoma having ATCC Accession Number HB 10916 |
| 07/15/2003 | US6592819 Improved spotting of specific binding substances |
| 07/15/2003 | CA2122717C Hemoglobins as drug delivery agents |
| 07/15/2003 | CA2063352C Cloning and expression of acetyl xylan esterases from fungal origin |
| 07/15/2003 | CA2058820C Expression cassettes and vectors for the secretion of human serum albumin in pichia pastoris cells |
| 07/11/2003 | CA2367543A1 Yeast transport isoforms |
| 07/10/2003 | WO2003056458A1 Est arrangement mapping method and mapping program |
| 07/10/2003 | WO2003056340A2 Fadd proteins, phosphorylated p38-mapk and fasl as tumour markers |
| 07/10/2003 | WO2003056336A2 Improved structured-functional bonding matrices for biomolecules |
| 07/10/2003 | WO2003056297A2 Self-assembling polymers, and materials fabricated therefrom |
| 07/10/2003 | WO2003056034A2 Method for the in vitro selection of binders |
| 07/10/2003 | WO2003056032A1 Amp kinase beta-subunit oligosaccharide binding domain |
| 07/10/2003 | WO2003056026A1 Process for production of glutamic acid derivatives |
| 07/10/2003 | WO2003056023A1 Double-stranded cyclic dna capable of proliferating as artificial e. coli chromosome |
| 07/10/2003 | WO2003056022A2 Method for producing a transgenic organism using a lentiviral expression vector such as eiav |
| 07/10/2003 | WO2003056021A2 Modified tetracycline repressor protein compositions and methods of use |
| 07/10/2003 | WO2003056020A2 Expression vectors and promoters for heterologous gene expression |
| 07/10/2003 | WO2003056019A1 Method of transducing es cells |
| 07/10/2003 | WO2003056018A1 Pyroglutamyl peptidase and its gene |
| 07/10/2003 | WO2003056017A2 Alkaline protease from bacillus sp. (dsm 14390) and washing and cleaning products comprising said alkaline protease |
| 07/10/2003 | WO2003056016A1 Fungus-origin lysyl oxidases |
| 07/10/2003 | WO2003056015A1 Bacterial superantigen vaccines |
| 07/10/2003 | WO2003056014A1 Regulation of human mono (adp-ribosyl) transferase-like protein |
| 07/10/2003 | WO2003056013A1 TGF-β-SPECIFIC COVALENTLY CLOSED ANTISENSE MOLECULE |
| 07/10/2003 | WO2003056012A1 A system for stable expression of sirnas in mammalian cells |
| 07/10/2003 | WO2003056011A2 Therapeuticum and prophylacticum for malignant diseases using phenotype suppression |
| 07/10/2003 | WO2003056010A2 An antisense strategy to modulate estrogen receptor response (er. alpha. and/or er. beta.) |
| 07/10/2003 | WO2003056009A1 Nucleotide sequences having activity of controlling translation efficiency and utilization thereof |
| 07/10/2003 | WO2003056008A1 Regulation of the expression of bacterial motility-associated genes |
| 07/10/2003 | WO2003056006A1 Method of detecting mutation in human serotonin receptor subtype 2b gene |
| 07/10/2003 | WO2003055998A2 Process for the preparation of a beta-lactam antibiotic with mutated penicillin acylase |
| 07/10/2003 | WO2003055997A1 Genomic sequences encoding dendritic cell expressed s-adenosyl homocysteine hydrolase like molecules |
| 07/10/2003 | WO2003055996A1 Eubacterial rna-polymerase mutants with altered product production |
| 07/10/2003 | WO2003055995A2 Lipase genes and proteins |
| 07/10/2003 | WO2003055994A1 Hxhv virus, nucleic material, peptide material and uses |
| 07/10/2003 | WO2003055989A2 Cellular compositions and methods of making and using them |
| 07/10/2003 | WO2003055983A2 Targeted retrograde gene delivery to motor neurons |
| 07/10/2003 | WO2003055980A2 Il-17 like molecules and uses thereof |
| 07/10/2003 | WO2003055978A2 Gene recombination and hybrid protein development |
| 07/10/2003 | WO2003055977A2 A method for generating overexpression of alleles in genes of unknown function |
| 07/10/2003 | WO2003055974A2 Novel alkaline protease from bacillus sp. (dsm 14392) and washing and cleaning products comprising said novel alkaline protease |
| 07/10/2003 | WO2003055973A1 Reaction container and reaction container holding mechanism |
| 07/10/2003 | WO2003055917A2 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours |
| 07/10/2003 | WO2003055916A2 Adiponectin fragments and conjugates |
| 07/10/2003 | WO2003055915A2 Human netrin receptor and uses thereof |
| 07/10/2003 | WO2003055913A2 Secreted protein |
| 07/10/2003 | WO2003055912A2 Secreted proteins |
| 07/10/2003 | WO2003055911A2 Cystine-knot fold protein |
| 07/10/2003 | WO2003055910A1 Beta-amyloid binding factors and inhibitors thereof |
| 07/10/2003 | WO2003055909A1 Regulation of human fatty acid binding protein |
| 07/10/2003 | WO2003055908A2 Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases |
| 07/10/2003 | WO2003055906A1 Modified bacterial surface layer proteins |